Literature DB >> 12951308

When and how should we screen for hereditary hemochromatosis?

Gérard Chalès1, Pascal Guggenbuhl.   

Abstract

Hemochromatosis is the clinical expression of iron overload and occurs as hereditary and secondary variants. In hereditary hemochromatosis, an inborn error in iron metabolism results in excess absorption of dietary iron, which gradually accumulates in the liver, pancreas, and heart. The most common form of hereditary hemochromatosis is related to homozygosity for the C282Y mutation in the HFE gene. Early diagnosis is essential because hereditary hemochromatosis is common, severe, and treatable. Early manifestations consist of asthenia, arthralgia, and serum transferrin saturation elevation. The C282Y mutation should be looked for to confirm the diagnosis in the patient and family members. Measurement of serum transferrin saturation followed by genetic testing in individuals with values above 45% is a reasonable screening strategy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951308     DOI: 10.1016/s1297-319x(03)00035-6

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  3 in total

1.  Bone mineral density in men with genetic hemochromatosis and HFE gene mutation.

Authors:  P Guggenbuhl; Y Deugnier; J F Boisdet; Y Rolland; A Perdriger; Y Pawlotsky; G Chalès
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

2.  Compound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidney.

Authors:  Barbara Kaczorowska-Hac; Katarzyna Sikorska; Krzysztof P Bielawski; Krystyna Schramm; Anna Balcerska
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

Review 3.  Iron metabolism: from health to disease.

Authors:  Fernando Oliveira; Sara Rocha; Rúben Fernandes
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.